Cargando…

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) is a highly prevalent malignancy that develops in patients with chronic liver diseases and dysregulated systemic and hepatic immunity. The tumor microenvironment (TME) contains tumor-associated macrophages (TAM), cancer-associated fibroblasts (CAF), regulatory T cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lurje, Isabella, Werner, Wiebke, Mohr, Raphael, Roderburg, Christoph, Tacke, Frank, Hammerich, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137829/ https://www.ncbi.nlm.nih.gov/pubmed/34025657 http://dx.doi.org/10.3389/fimmu.2021.650486

Ejemplares similares

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)

Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
por: Lurje, Isabella, et al.
Publicado: (2020)

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
por: Laschtowitz, Alena, et al.
Publicado: (2023)

Treatment Strategies for Hepatocellular Carcinoma—A Multidisciplinary Approach
por: Lurje, Isabella, et al.
Publicado: (2019)

Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer
por: Shetty, Shishir, et al.
Publicado: (2021)

Cholangiokines: undervalued modulators in the hepatic microenvironment
por: Cai, Xiurong, et al.
Publicado: (2023)

Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
por: Miller, Hannah, et al.
Publicado: (2020)

Pulmonary Complications in Patients with Liver Cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
por: Eschrich, Johannes, et al.
Publicado: (2023)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
por: Lambrecht, Joeri, et al.
Publicado: (2021)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The role of the innate immune system in the development and treatment of hepatocellular carcinoma
por: Roderburg, Christoph, et al.
Publicado: (2020)

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021)

Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2022)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

Interleukins in chronic liver disease: lessons learned from experimental mouse models
por: Hammerich, Linda, et al.
Publicado: (2014)

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma?
por: Vucur, Mihael, et al.
Publicado: (2010)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2021)

Role of IL-17 and Th17 Cells in Liver Diseases
por: Hammerich, Linda, et al.
Publicado: (2011)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023)

Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
por: Li, Tanghua, et al.
Publicado: (2023)

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
por: Laschtowitz, Alena, et al.
Publicado: (2023)

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
por: Koske, Iris, et al.
Publicado: (2019)

Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment
por: Li, Zuyin, et al.
Publicado: (2022)

Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma
por: Xiang, Lin, et al.
Publicado: (2022)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
por: Yoshida, Sumito, et al.
Publicado: (2019)

Strategies to overcome DC dysregulation in the tumor microenvironment
por: Mestrallet, Guillaume, et al.
Publicado: (2022)

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023)

Neurotransmitters: promising immune modulators in the tumor microenvironment
por: Xiao, Luxi, et al.
Publicado: (2023)

PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
por: Li, Tian-En, et al.
Publicado: (2020)

Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2021)

Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling
por: Yang, Jian, et al.
Publicado: (2023)

Barriers to Radiation-Induced In Situ Tumor Vaccination
por: Wennerberg, Erik, et al.
Publicado: (2017)

The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer
por: Chen, Yaping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nooneeg9plgddpakuce1jpoovv